A technology has been developed that uses robots rather than humans to evaluate the performance of newly developed catalysts. By operating 45 times faster than manual work while also improving ...

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...

1 Department of Oral Implantology, Jacksonville University, Jacksonville, USA. 2 Department of Mechanical Engineering, University of Connecticut, Storrs, USA. After cleaning and shaping during ...

Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence IDEXX Laboratories, Inc. (NASDAQ: IDXX), ...

Researchers have developed a way to 3D print custom micrometer-sized structures directly into the interior of living cells. As reported in Advanced Materials, the investigators used their method to ...

Florida's two-year-old school cellphone ban has not improved standardized test scores, which have fallen to a 20-year low. The author argues that cellphones are a symptom of student disengagement, not ...

Student test scores in the U.S. are down from where they were a decade ago. The trend is one that education researchers accept but took most of the decade to identify. Prior to the COVID-19 pandemic, ...

Scientists have discovered a method of helping human stem cells thrive in an animal embryo—a key development in efforts to grow human organs in animals for medical transplants. A study by UT ...

Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...

LOUISVILLE, Ky. (WDRB) -- Researchers at the Indiana University School of Medicine are developing new ways to fight tumors and aggressive forms of cancer—such as triple-negative breast cancer, ...

A Pfizer drug designed to address a severe problem associated with sickle cell disease failed to beat a placebo in a Phase 3 clinical trial. It’s the latest setback for Pfizer in this inherited blood ...